CXCL16 and glioblastoma: Inhibition of CXCL16 has been linked to ameliorating effects in a variety of inflammatory related diseases such as liver inflammation and steatohepatitis [288], anti-GBM glomerulonephritis [289] and the regulation of CIAKI [47].